13 14 Beyond lowering fat accumulation in the liver, GLP-1s also improve liver-driven heart risk by decreasing inflammation and reducing levels of enzymes that release artery-damaging particles
Systemic side effects Nausea is the most commonly reported side effect of GLP-1 therapy, and it is a medication effect, not an injection technique issue
Liver injury has not been established as a common expected side effect of regulated retatrutide used in clinical trials
TRIUMPH-4 is the first pivotal trial to confirm that the weight-loss signal seen in Phase 2 scales with longer exposure and higher doses, and it adds several new secondary findings that reshape how researchers think about 9 mg and 12 mg as working doses
You should contact your GP if natural approaches to improving metabolic health have not yielded results after 3-6 months, if you have been diagnosed with type 2 diabetes or non-diabetic hyperglycaemia (pre-diabetes, HbA1c 42-47 mmol/mol), if you are struggling with obesity-related health complications, or if you experience unexplained weight changes, persistent fatigue, or excessive thirst and urination
Instead of targeting just one problem, these drugs attack multiple problems simultaneously